Search Results

Genflow Biosciences Plc an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that all resolutions proposed at the Annual General Meeting held earlier were duly passed.

ICON plc, a world-leading healthcare intelligence and clinical research organization, announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.

ANGLE plc announces unaudited preliminary results for the year ended 31 December 2023.

Hemogenyx Pharmaceuticals plc is pleased to announce that, at the Annual General Meeting held earlier , all resolutions were duly passed on a show of hands.

Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.

Genflow Biosciences Plc is pleased to announce receipt of 50% of its substantial non-diluting and non-reimbursable research grant.

Genflow Biosciences Plc is pleased to announce that it will hold its Annual General Meeting at 12pm on Thursday 27 June 2024 at 1 Heddon Street, London, W1B 4BT.

Takeda announced that, on October 17, 2023, it agreed with the Irish Revenue Commissioners to settle a tax assessment related to the treatment of an acquisition break fee received by Shire plc in October 2014 from AbbVie Inc., for EUR 130 million, resulting in a tax expense reduction of approximately JPY 63 billion for Takeda.

ANGLE plc is pleased to announce its participation at the 2024 Annual Congress of the European Association for Cancer Research being held in Rotterdam, Netherlands from 10 to 13 June 2024.

ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell solutions for use in research, drug development and clinical oncology, announces that the audited Annual Report and Financial Statements for the year ended 31 December 2023, and the Notice of Annual General Meeting within it, have been posted to shareholders, and are available on the Company’s website.